Drug Trial Radar · NCT01124149
Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis
Last checked: Nov 19, 2026Latest source record: Jun 9, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
759
Actual
Start
Jun 29, 2010
Primary completion
Dec 7, 2012
Study completion Dec 7, 2012
Sponsor
- Lead sponsor
- ShireTakeda (TAK)
- Sponsor type
- Industry
- First posted
- May 14, 2010
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study was designed to evaluate if subjects who achieve complete remission after 8 weeks of acute therapy with MMX mesalamine/mesalazine 4.8g/day given QD have better long-term outcomes and remain in remission longer compared with subjects who demonstrate only partial remission after acute therapy with MMX mesalamine/mesalazine 4.8g/day given QD. Therefore, subjects who achieve either complete or partial remission will enter into a 12-month maintenance phase, during which they will receive MMX mesalamine/mesalazine 2.4g/day given QD. Remission status for the 2 groups will be evaluated and compared at the end of this 12-month maintenance period. The data obtained from this study will provide scientifically meaningful information to demonstrate that achieving complete remission (clinical and endoscopic remission) is important for a better long-term prognosis, or that the current paradigm of symptomatic treatment is appropriate.
Conditions
- Ulcerative Colitis
Interventions
MMX mesalamine/ mesalazineDrug
4.8g/day given QD (four 1.2g tablets) for 8 weeks, 2.4g/day given QD (two 1.2g tablets) for 12 months
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Subjects in Complete Remission at Month 12 of Maintenance PhaseTime frame: 12 months
Locations
105 sites in 15 countries. Site status is shown where the registry gives one.
Birmingham Gastroenterology Associates, PC
Birmingham, Alabama
Advanced Clinical Research Institute
Anaheim, California
Digestive & Liver Disease Specialists
Garden Grove, California
Long Beach VA Medical Center
Long Beach, California
Clinical Applications Laboratories, Inc.
San Diego, California
Conneticut Gastroenterolgy Institute
Bristol, Connecticut
Borland-Groover Clinic
Jacksonville, Florida
United Medical Research
New Smyrna Beach, Florida
Advances Gastroenterology Associates
Palm Harbor, Florida
Atlanta Gastroenterology Associates, LLC
Atlanta, Georgia
Atlanta Gastroenterology Associates
Marietta, Georgia
University of Chicago Medical Center
Chicago, Illinois
Midwest Clinical Research Associates
Moline, Illinois
Gastrointestinal Clinic of Quad Cities
Davenport, Iowa
New Orleans Research Institute
Metairie, Louisiana
Delta Research Partners
Monroe, Louisiana
Louisiana Research Center, LLC
Shreveport, Louisiana
Digestive Disorders Associates
Annapolis, Maryland
Digestive Disease Associates
Baltimore, Maryland
Center for Digestive Health
Troy, Michigan
Mayo Clinic
Rochester, Minnesota
Center for Digestive & Liver Disease, Inc.
Mexico, Missouri
Long Island Clinical Research Associates, LLP
Great Neck, New York
Gastrointestinal Research Associates
Setauket, New York
LeBauer Research Associates
Greensboro, North Carolina
Ohio Gastroenterolgy and Liver Intstitute
Cincinnati, Ohio
Regional Gastroenterology Associates of Lancaster, Ltd.
Lancaster, Pennsylvania
Gastroenterology Associates, LLC
Kingsport, Tennessee
S.D. Khan
Houston, Texas
Gastroenterology Clinic of San Antonio, PA
San Antonio, Texas
Colon and Rectal Disease Center
Sandy City, Utah
Physicians Research Option, LLC
Sandy City, Utah
Alexandria Clinical Research
Alexandria, Virginia
Wisconsin Center for Advances Research
Milwaukee, Wisconsin
Imelda General Hospital
Bonheiden, Belgium
vzw AZ Groeninge
Kortrijk, Belgium
Heilig Hart ziekenhuis vzw Roeselare-Menen
Roeselare, Belgium
McMaster University Medical Centre
Hamilton, Ontario, Canada
Toronto Digestive Disease Associates, Inc.
Toronto, Ontario, Canada
Royal Victoria Hospital
Montreal, Quebec, Canada
Showing 40 of 105 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.